HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumors
HERTHENA-PanTumor01:一项针对既往接受过治疗的晚期实体瘤患者的帕妥珠单抗德鲁替康(HER3-DXd)II期研究
期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2561539
Powles, Thomas; Bhatia, Aarti; Burtness, Barbara; Kogawa, Takahiro; Nishina, Tomohiro; Nakayama, Izuma; Fountzilas, Christos; Castillo, Dani R; McKean, Meredith; Meric-Bernstam, Funda; Colombo, Nicoletta; Smithy, James W; Fayette, Jérome; Chandra, Sunandana; Sternberg, David W; Jin, Fan; Sullivan, Kendall; Yueh, Sue; Clinthorne, Graham; Aguilo, Ariel E; Kudchadkar, Ragini; Hayashi, Hidetoshi